Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.51.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.526 (Iota)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.621 (Mu)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.47 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.17 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.126 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.48 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.116.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.52 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.13 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.35 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.7 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.120.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.107NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.172NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.91NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.55.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.120 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used